Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

0.8300 -0.0100 (-1.19%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	141,997
Open	0.8400
Bid (Size)	0.8306 (200)
Ask (Size)	0.8500 (200)
Prev. Close	0.8400
Today's Range	0.8300 - 0.8700
52wk Range	0.6930 - 13.50
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Q2 Virtual Investor Summit Presentations Now Available On Demand

June 30, 2026

From Investor Summit Group

Via ACCESS Newswire

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

June 22, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

Performance

YTD	-32.0%	-32.0%
1 Month	-50.6%	-50.6%
3 Month	-78.8%	-78.8%
6 Month	-32.0%	-32.0%
1 Year	-90.5%	-90.5%

More News

bioAffinity Technologies Announces Closing of $3.2 Million Offering

June 18, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Pricing of $3.2 Million Offering

June 17, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

June 16, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

June 02, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology

May 27, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

May 12, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

May 08, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

Which stocks are experiencing notable movement on Tuesday? ↗

April 28, 2026

Via Chartmill

bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment

April 28, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

April 14, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16

April 07, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026

April 01, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

What's Going On With bioAffinity Technologies Stock Wednesday? ↗

March 25, 2026

Via Benzinga

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice

March 25, 2026

From bioAffinity Technologies, Inc.

Via Business Wire

What's going on in today's session ↗

March 23, 2026

Via Chartmill

These stocks are moving in today's session ↗

March 23, 2026

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

March 20, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

March 20, 2026

Via Chartmill

Discover the top movers in Wednesday's pre-market session. ↗

March 18, 2026

Via Chartmill

These stocks are the most active in today's session ↗

March 17, 2026

Via Chartmill

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

March 17, 2026

Via Chartmill

Top stock movements in today's session. ↗

March 17, 2026

Via Chartmill

Gapping stocks in Tuesday's session ↗

March 17, 2026

Via Chartmill

Frequently Asked Questions

Is bioAffinity Technologies, Inc. - Common Stock publicly traded?

Yes, bioAffinity Technologies, Inc. - Common Stock is publicly traded.

What exchange does bioAffinity Technologies, Inc. - Common Stock trade on?

bioAffinity Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for bioAffinity Technologies, Inc. - Common Stock?

The ticker symbol for bioAffinity Technologies, Inc. - Common Stock is BIAF on the Nasdaq Stock Market

What is the current price of bioAffinity Technologies, Inc. - Common Stock?

The current price of bioAffinity Technologies, Inc. - Common Stock is 0.8300

When was bioAffinity Technologies, Inc. - Common Stock last traded?

The last trade of bioAffinity Technologies, Inc. - Common Stock was at 07/02/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.